InnoSIGN is a biotech company that takes a biology-first approach to analyzing the relationships and interactions between signaling pathways to discern a series of disease driver events. Our proprietary platform quantifies the activity of 10+ essential disease-driving pathways by leveraging our proprietary structured ML algorithms developed over 10 years of research at Philips. We enable our partners to gain more insights and accelerate their discoveries and innovations.
Company Details
- Employees
- 9
- Founded
- -
- Address
- High Tech Campus 11, Eindhoven,5656 Ae,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.innosignbio.com
- Keywords
- diagnostics, oncology, biotech, precision medicine, molecular diagnostics, genomics, oncosignal, signaling pathways.
- HQ
- Eindhoven
Innosign Questions
Innosign's website is http://www.innosignbio.com
Innosign's LinkedIn profile is https://www.linkedin.com/company/innosignbio
Innosign has
9 employees.
View email and phone details for 9
employees at Innosign.
Innosign's industry is
Biotechnology Research
Innosign's top competitors are
Scipher Medicine,
Autonomy Bio,
Companion Bio,
Ribopro,
Process-It,
Zephyr Ai,
Xyall,
Offilancer,
Detectivio,
Mira Precision Health.
Innosign's categories are Biotechnology Research
Innosign's founding year is 2022
